𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Integrated pharmacokinetics and pharmacodynamics of atropine in healthy humans II: Pharmacodynamics

✍ Scribed by Peter H. Hinderling; Ursula Gundert-Remy; Olga Schmidliny; Günther Heinzel


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
829 KB
Volume
74
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

✦ Synopsis


This study determined the kinetics of the effects of atropine on heart rate and saliva flow in three healthy male volunteers after intravenous administration of 1.35 and 2.15 mg of the drug. The pharmacokinetics of atropine and its primary metabolite, tropine, were determined simultaneously. Both the pharmacokinetic and effect data were fitted to an integrated kinetic-dynamic model. The maximum heart rate and minimum saliva flow occurred with a significant delay of 7-8 rnin after drug administration. Both effects were nonlinearly related to the amount of drug in the peripheral compartment. Maximum heart rates of 192 and 217% of the control values were observed at the lower and


📜 SIMILAR VOLUMES


Pharmacokinetics and pharmacodynamics of
✍ Capecchi, Pier Leopoldo; Blardi, Patrizia; De Lalla, Arianna; Ceccatelli, Linda; 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 865 KB

Object&e: To study the possibility that the penetration of the antibiotic ciprofloxacin into polymorphonuclear leukocytes (PMN) may be associated with some changes in cell reactivity. Design: Superoxide anion and chemkminescence generation induced by formyl-methionyl-leucylphenylalanine (fMLP) and p

Pharmacokinetics, pharmacodynamics and d
✍ Al-Ghananeem, Abeer M. (author) 📂 Article 📅 2009 🏛 John Wiley and Sons Inc. 🌐 English ⚖ 170 KB

The objective of this study was to characterize the clinical pharmacokinetic profile of lofexidine after oral delivery. A single dose, cross-over study and a multidose study using healthy volunteers were conducted for that purpose. In the single dose study the average time to maximum concentration w

A review of the pharmacokinetics, tolera
✍ P. Rosenzweig; M. Canal; A. Patat; L. Bergougnan; I. Zieleniuk; G. Bianchetti 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Amisulpride binds selectively to dopamine D(2) and D(3) receptors in the limbic system. Low doses of amisulpride preferentially block presynaptic D(2)/D(3)-dopamine autoreceptors, thereby enhancing dopaminergic transmission, whereas higher doses block postsynaptic receptors, thus inhibiting dopamine